Constance Keyserling
Chief Operating Officer chez ABIONYX PHARMA
Profil
Constance Keyserling is currently the Director of Clinical Development & Operations at ABIONYX Pharma SA. Previously, she held positions as the Senior Director of Operations at Esperion Therapeutics, Inc., Manager of Clinical Research Operations at Pfizer Inc., Vice President of Development Operations at QuatRx Pharmaceuticals Co., and Manager of Clinical Research Operations at Parke, Davis & Co. LLC.
She obtained her graduate degree from Harvard University in 1984.
Postes actifs de Constance Keyserling
| Sociétés | Poste | Début |
|---|---|---|
| ABIONYX PHARMA | Chief Operating Officer | - |
Anciens postes connus de Constance Keyserling
| Sociétés | Poste | Fin |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | - |
| ESPERION THERAPEUTICS, INC. | Chief Operating Officer | - |
| Parke, Davis & Co. LLC | Corporate Officer/Principal | - |
QuatRx Pharmaceuticals Co.
 QuatRx Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology QuatRx Pharmaceuticals Co. manufactures and develops therapeutic compounds. Its clinical products, ospemifene and fispemifene, treat hormone deficiencies that result from aging in women and men. The firm's preclinical program is designed to address sex steroid dependent diseases through inhibition of 17beta- hydroxysteroid dehydrogenase (HSD) enzymes. The company was founded by Robert Zerbe, Christopher Nicholas, and Stuart Dombey on November 20 2000 and is headquartered in Ann Arbor, MI. | Corporate Officer/Principal | - |
Formation de Constance Keyserling
| Harvard University | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| ESPERION THERAPEUTICS, INC. | Health Technology |
| ABIONYX PHARMA | Health Technology |
| Entreprise privées | 2 |
|---|---|
QuatRx Pharmaceuticals Co.
QuatRx Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology QuatRx Pharmaceuticals Co. manufactures and develops therapeutic compounds. Its clinical products, ospemifene and fispemifene, treat hormone deficiencies that result from aging in women and men. The firm's preclinical program is designed to address sex steroid dependent diseases through inhibition of 17beta- hydroxysteroid dehydrogenase (HSD) enzymes. The company was founded by Robert Zerbe, Christopher Nicholas, and Stuart Dombey on November 20 2000 and is headquartered in Ann Arbor, MI. | Health Technology |
| Parke, Davis & Co. LLC |
